Previous Close | 153.06 |
Open | 153.06 |
Bid | 154.14 x 0 |
Ask | 154.32 x 0 |
Day's Range | 153.06 - 153.06 |
52 Week Range | 119.90 - 167.52 |
Volume | |
Avg. Volume | 10 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Apr 26, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Key Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to their trading...
AbbVie (NYSE: ABBV) will announce its second-quarter 2024 financial results on Thursday, July 25, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.